Flow cytometric analysis of VEGFR1 in the MDSC fraction of CD11B+ cells (defined as CD11B+ CD14− HLA− CD33+) also revealed elevated protein levels in stage IV melanoma patients compared with controls (unpaired t-test, P<0.001; Fig. 7d). This evidence concerns the gene CD33 and melanoma.